Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRB10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PLIN3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | TRIM67 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PLEKHM3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZMYM4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZCWPW1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | C20orf96 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ERRFI1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | FADS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |